Literature DB >> 25879083

Tissue Plasminogen Activator: Side Effects and Signaling.

Ling Lin, Kebin Hu.   

Abstract

Entities:  

Year:  2014        PMID： 25879083      PMCID： PMC4394626     

Source DB:  PubMed          Journal:  J Drug Des Res


× No keyword cloud information.
  36 in total

1.  Tissue plasminogen activator (tPA) increases neuronal damage after focal cerebral ischemia in wild-type and tPA-deficient mice.

Authors:  Y F Wang; S E Tsirka; S Strickland; P E Stieg; S G Soriano; S A Lipton
Journal:  Nat Med       Date:  1998-02       Impact factor: 53.440

2.  Tissue type plasminogen activator amplifies hemoglobin-induced neurotoxicity in rat neuronal cultures.

Authors:  X Wang; M Asahi; E H Lo
Journal:  Neurosci Lett       Date:  1999-10-22       Impact factor: 3.046

3.  Tissue plasminogen activator mediates microglial activation via its finger domain through annexin II.

Authors:  Chia-Jen Siao; Stella E Tsirka
Journal:  J Neurosci       Date:  2002-05-01       Impact factor: 6.167

4.  Tissue plasminogen activator activates NF-κB through a pathway involving annexin A2/CD11b and integrin-linked kinase.

Authors:  Ling Lin; Chuanyue Wu; Kebin Hu
Journal:  J Am Soc Nephrol       Date:  2012-06-07       Impact factor: 10.121

5.  Tissue plasminogen activator increases canine endothelial cell proliferation rate through a plasmin-independent, receptor-mediated mechanism.

Authors:  T H Welling; T S Huber; L M Messina; J C Stanley
Journal:  J Surg Res       Date:  1996-11       Impact factor: 2.192

6.  Activation of hepatocyte growth factor by the plasminogen activators uPA and tPA.

Authors:  W M Mars; R Zarnegar; G K Michalopoulos
Journal:  Am J Pathol       Date:  1993-09       Impact factor: 4.307

7.  Ligand binding to LRP1 transactivates Trk receptors by a Src family kinase-dependent pathway.

Authors:  Yang Shi; Elisabetta Mantuano; Gen Inoue; W Marie Campana; Steven L Gonias
Journal:  Sci Signal       Date:  2009-04-28       Impact factor: 8.192

8.  Tissue-type plasminogen activator promotes murine myofibroblast activation through LDL receptor-related protein 1-mediated integrin signaling.

Authors:  Kebin Hu; Chuanyue Wu; Wendy M Mars; Youhua Liu
Journal:  J Clin Invest       Date:  2007-12       Impact factor: 14.808

9.  Tissue plasminogen activator is a potent activator of PDGF-CC.

Authors:  Linda Fredriksson; Hong Li; Christina Fieber; Xuri Li; Ulf Eriksson
Journal:  EMBO J       Date:  2004-09-16       Impact factor: 11.598

10.  Dissection of receptor folding and ligand-binding property with functional minireceptors of LDL receptor-related protein.

Authors:  L M Obermoeller-McCormick; Y Li; H Osaka; D J FitzGerald; A L Schwartz; G Bu
Journal:  J Cell Sci       Date:  2001-03       Impact factor: 5.285
View more
  2 in total

1.  Lentivirus- or AAV-mediated gene therapy interventions in ischemic stroke: A systematic review of preclinical in vivo studies.

Authors:  Laura Skukan; Matea Brezak; Rok Ister; Lars Klimaschewski; Aleksandar Vojta; Vlatka Zoldoš; Srećko Gajović
Journal:  J Cereb Blood Flow Metab       Date:  2021-08-24       Impact factor: 6.960

2.  Recombinant Tissue Plasminogen Activator (r-tPA) Induces In-Vitro Human Neutrophil Migration via Low Density Lipoprotein Receptor-Related Protein 1 (LRP-1).

Authors:  Luca Liberale; Maria Bertolotto; Silvia Minetti; Paola Contini; Daniela Verzola; Pietro Ameri; Giorgio Ghigliotti; Aldo Pende; Giovanni G Camici; Federico Carbone; Fabrizio Montecucco
Journal:  Int J Mol Sci       Date:  2020-09-23       Impact factor: 5.923
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.